Christine Radawski
Christine Radawski publishes mostly in Economics and Econometrics, Rheumatology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Health Systems, Economic Evaluations, Quality of Life and Pharmacovigilance and Adverse Drug Reactions.
- World rank
- #4,009,343 of 7,710,434 ranked researchers
- Rank in United States
- #1,093,153 of 1,627,098
- Works
- 18
- Citations
- 215
- Citations per work
- 11.9
What does Christine Radawski research?
Christine Radawski's work is mostly in Economics, Econometrics and Finance (22%), Medicine (16%), Immunology and Microbiology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else631.4%
- Health Sciences423.5%
- Medicine315.7%
- Health Professions17.8%
- Life Sciences423.5%
- Social Sciences421.6%
- 1Economics and Econometrics22% of their works
- 2Rheumatology16% of their works
- 3Immunology10% of their works
- 4General Health Professions8% of their works
- 5Toxicology8% of their works
- 6Genetics6% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacovigilance and Adverse Drug Reactions
- Inflammatory Bowel Disease
- Economic and Environmental Valuation
- Psoriasis: Treatment and Pathogenesis
- Biosimilars and Bioanalytical Methods
- Pharmaceutical industry and healthcare
Which keywords describe Christine Radawski's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Inflammation, Quality of Life, Rheumatoid Arthritis, Adverse Drug Reactions, Pharmacovigilance, Conjoint Analysis and Crohn's Disease.
- TH17 Cells
- Immunogenicity
- Conflict of Interest
- Inflammatory Bowel Disease
- Crohn's Disease
- Pharmacovigilance
- Rheumatoid Arthritis
- Inflammation
- Cost-effectiveness Analysis
- Quality of Life
- Adverse Drug Reactions
- Conjoint Analysis
- Discrete Choice Models
- Biosimilars
- IL-17
- Pharmaceutical Industry
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost-effectiveness Analysis71 topic
- Inflammation71 topic
- Quality of Life71 topic
- Rheumatoid Arthritis71 topic
- Adverse Drug Reactions41 topic
- Pharmacovigilance41 topic
- Conjoint Analysis31 topic
- Crohn's Disease31 topic
- Discrete Choice Models31 topic
- Inflammatory Bowel Disease31 topic
- Biosimilars21 topic
- Conflict of Interest21 topic
- IL-1721 topic
- Immunogenicity21 topic
- Pharmaceutical Industry21 topic
- TH17 Cells21 topic
Where does Christine Radawski work?
Christine Radawski's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Christine Radawski have?
OpenAlex counts 18 works and 215 citations for Christine Radawski, an h-index of 8, ranking #4,009,343 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christine Radawski. Posts are plain text and can be reported.